Inhibition of the Rho GTPase, Rac1, decreases estrogen receptor levels and is a novel therapeutic strategy in breast cancer

Adena E. Rosenblatt, Maria Ines Garcia, Leah Lyons, Yingqiu Xie, Carol Maiorino, Laurent Désiré, Joyce Slingerland, Kerry L. Burnstein

Research output: Contribution to journalArticle

33 Scopus citations

Fingerprint Dive into the research topics of 'Inhibition of the Rho GTPase, Rac1, decreases estrogen receptor levels and is a novel therapeutic strategy in breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences